151 related articles for article (PubMed ID: 2971278)
1. [Cyproterone acetate. Its value in the treatment of prostatic cancer. Apropos of 45 cases].
Tobelem G; Arvis G
Therapie; 1988 May; 43(3):179-82. PubMed ID: 2971278
[No Abstract] [Full Text] [Related]
2. [Cyproterone acetate and cancer of the prostate. Experience in 46 cases].
Tauveron I; Hermabessière J
Therapie; 1988 May; 43(3):175-7. PubMed ID: 2971277
[No Abstract] [Full Text] [Related]
3. Cyproterone acetate in the management of prostatic cancer.
Tunn UW
Prog Clin Biol Res; 1989; 303():105-10. PubMed ID: 2528734
[No Abstract] [Full Text] [Related]
4. EORTC protocol 30761: a randomized study of non-metastatic and metastatic prostatic cancer treated by cyproterone acetate versus diethylstilbestrol and medroxyprogesterone acetate. European Organization for Research on Treatment of Cancer Urological Group.
Pavone-Macaluso M; Schröder FH; de Voogt HJ; Viggiano G; Barasolo E; Lardennois B; de Pauw M; Sylvester R; Smith PH; Suciu S
Prog Clin Biol Res; 1989; 303():111-6. PubMed ID: 2528735
[No Abstract] [Full Text] [Related]
5. The combination of cyproterone acetate and low dose diethylstilbestrol in the treatment of advanced prostatic carcinoma.
Goldenberg SL; Bruchovsky N; Rennie PS; Coppin CM
J Urol; 1988 Dec; 140(6):1460-5. PubMed ID: 2973529
[TBL] [Abstract][Full Text] [Related]
6. Advantages and disadvantages of pure antiandrogens and of antiandrogens of the cyproterone acetate-type in the treatment of prostatic cancer.
Habenicht UF; Schröder H; el Etreby MF; Neumann F
Prog Clin Biol Res; 1988; 260():63-75. PubMed ID: 2966407
[No Abstract] [Full Text] [Related]
7. Treatment of advanced prostatic cancer with anti-androgens alone and a combination of anti-androgen with anti-prolactin--a pilot study.
Hoogendijk E; de Voogt HJ
Urol Res; 1986; 14(3):129-31. PubMed ID: 2944268
[TBL] [Abstract][Full Text] [Related]
8. Cyproterone acetate in treatment of post-orchidectomy hot flushes. Double-blind cross-over trial.
Eaton AC; McGuire N
Lancet; 1983 Dec; 2(8363):1336-7. PubMed ID: 6139671
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Zoladex, diethylstilbestrol and cyproterone acetate treatment in advanced prostate cancer.
Moffat LE
Eur Urol; 1990; 18 Suppl 3():26-7. PubMed ID: 2151272
[No Abstract] [Full Text] [Related]
10. [Cyproterone acetate in the treatment of post-orchiectomy flushing].
Jansen JE; Hendriksen ON
Ugeskr Laeger; 1989 Feb; 151(9):560-1. PubMed ID: 2522257
[TBL] [Abstract][Full Text] [Related]
11. Extent of disease based on initial bone scan: important prognostic predictor for patients with metastatic prostatic cancer. Experience from the Scandinavian Prostatic Cancer Group Study No. 2 (SPCG-2).
Jørgensen T; Müller C; Kaalhus O; Danielsen HE; Tveter KJ
Eur Urol; 1995; 28(1):40-6. PubMed ID: 8521893
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of benign prostatic hyperplasia with antiandrogens (cyproterone acetate) and antiestrogens (tamoxifen)].
Giovannoni S; Tassi B
Minerva Urol Nefrol; 1987; 39(4):363-8. PubMed ID: 2453929
[No Abstract] [Full Text] [Related]
13. Pituitary adrenal and gonadal endocrine suppression for the primary treatment of prostate cancer.
Williams G; Asopa R; Abel PD; Smith C
Br J Urol; 1990 May; 65(5):504-8. PubMed ID: 2141289
[TBL] [Abstract][Full Text] [Related]
14. [Value of cyproterone acetate in the treatment of hirsutism].
Baron J; Chwalisz K; Warenik-Szymankiewicz A
Ginekol Pol; 1982 Apr; 53(4):283-7. PubMed ID: 6216148
[No Abstract] [Full Text] [Related]
15. Use of cyproterone acetate in prostate cancer.
Goldenberg SL; Bruchovsky N
Urol Clin North Am; 1991 Feb; 18(1):111-22. PubMed ID: 1825143
[TBL] [Abstract][Full Text] [Related]
16. The position of cyproterone acetate (CPA), a steroidal anti-androgen, in the treatment of prostate cancer.
de Voogt HJ
Prostate Suppl; 1992; 4():91-5. PubMed ID: 1533452
[TBL] [Abstract][Full Text] [Related]
17. [Antiandrogens in monotherapy or combined therapy for treatment of advanced cancer of the prostate].
Pavone-Macaluso M; Serretta V; Pavone C; Romano C; Daricello G
Arch Esp Urol; 1989; 42 Suppl 2():197-205. PubMed ID: 2534783
[TBL] [Abstract][Full Text] [Related]
18. [Cyproterone acetate].
Bercovici JP
Ann Endocrinol (Paris); 1983; 44(6):385. PubMed ID: 6234848
[No Abstract] [Full Text] [Related]
19. Short-term anti-androgen therapy and very long-acting depot gonadotrophin-releasing hormone agonist for prostatic cancer.
Waxman J
Prog Clin Biol Res; 1989; 303():61-8. PubMed ID: 2528741
[No Abstract] [Full Text] [Related]
20. Prostatic malignancy.
Paulson DF
J Urol (Paris); 1985; 91(7):401-7. PubMed ID: 4086873
[No Abstract] [Full Text] [Related]
[Next] [New Search]
